Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 33.11% is in line with its 5-year average of 30.12%, around the middle of its 5-year range (23.79%–43.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.46% above its 12-month average of 28.19%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
33.11%
RETURN ON EQUITY (ROE) AVG TTM
28.19%
RETURN ON EQUITY (ROE) AVG 3Y
25.55%
RETURN ON EQUITY (ROE) AVG 5Y
30.12%
RETURN ON EQUITY (ROE) AVG 10Y
29.27%
RETURN ON EQUITY (ROE) AVG 15Y
26.20%
RETURN ON EQUITY (ROE) AVG 20Y
23.66%
CURRENT VS TTM AVG
+17.46%
CURRENT VS 3Y AVG
+29.58%
CURRENT VS 5Y AVG
+9.93%
CURRENT VS 10Y AVG
+13.14%
CURRENT VS 15Y AVG
+26.38%
CURRENT VS 20Y AVG
+39.96%
SECTOR MEDIAN · HEALTHCARE
12.21%
median of 86 covered companies
CURRENT VS SECTOR MEDIAN
+171.18%
vs the sector median at left
Chemed Corporation
Market Cap
$6.80B
Return on Equity (ROE)
33.11%
TTM Avg
28.19%
3Y Avg
25.55%
5Y Avg
30.12%
Market Cap
$7.06B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$7.79B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$5.35B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$4.79B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$9.93B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$10.11B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
Market Cap
$10.28B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.37B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Chemed Corporation (CHE) | $6.80B | 33.11% | 28.19% | 25.55% | 30.12% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | -43.83% | 25.09% | 5.57% | 0.40% |
| Oscar Health, Inc. (OSCR)vs › | $7.79B | 26.84% | -21.41% | -36.14% | -25.75% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.35B | 8.67% | 8.42% | 7.80% | 5.80% |
| Doximity, Inc. (DOCS)vs › | $4.79B | 18.24% | 20.62% | 17.32% | 27.02% |
| Insulet Corp. (PODD)vs › | $9.93B | 26.39% | 25.41% | 19.99% | 14.02% |
| The Ensign Group, Inc. (ENSG)vs › | $10.11B | 15.51% | 15.81% | 15.92% | 17.27% |
| Henry Schein, Inc. (HSIC)vs › | $10.28B | 12.77% | 11.88% | 12.69% | 13.50% |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | -0.17% | 18.91% | 22.60% | 24.60% |
| TransMedics Group, Inc. (TMDX)vs › | $3.17B | 29.28% | 27.86% | 4.54% | -12.45% |
ROE
33.1%
ROA
17.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 33.11% |
| 2026-03-31 | 30.64% |
| 2025-12-31 | 27.08% |
| 2025-09-30 | 25.89% |
| 2025-06-30 | 24.23% |
| 2025-03-31 | 26.13% |
| 2024-12-31 | 26.99% |
| 2024-09-30 | 24.42% |
| 2024-06-30 | 24.92% |
| 2024-03-31 | 23.95% |
| 2023-12-31 | 24.60% |
| 2023-09-30 | 24.00% |
| 2023-06-30 | 23.79% |
| 2023-03-31 | 27.22% |
| 2022-12-31 | 31.25% |
| 2022-09-30 | 36.33% |
| 2022-06-30 | 40.48% |
| 2022-03-31 | 40.10% |
| 2021-12-31 | 43.09% |
| 2021-09-30 | 39.46% |
| 2021-06-30 | 34.84% |
| 2021-03-31 | 35.42% |
| 2020-12-31 | 35.45% |
| 2020-09-30 | 33.85% |
| 2020-06-30 | 34.97% |
| 2020-03-31 | 33.81% |
| 2019-12-31 | 30.27% |
| 2019-09-30 | 31.03% |
| 2019-06-30 | 32.49% |
| 2019-03-31 | 34.90% |
| 2018-12-31 | 34.76% |
| 2018-09-30 | 36.22% |
| 2018-06-30 | 34.14% |
| 2018-03-31 | 22.35% |
| 2017-12-31 | 18.17% |
| 2017-09-30 | 15.87% |
| 2017-06-30 | 14.83% |
| 2017-03-31 | 22.72% |
| 2016-12-31 | 20.75% |
| 2016-09-30 | 21.86% |
| 2016-06-30 | 23.50% |
| 2016-03-31 | 22.81% |
| 2015-12-31 | 21.49% |
| 2015-09-30 | 22.54% |
| 2015-06-30 | 22.16% |
| 2015-03-31 | 21.67% |
| 2014-12-31 | 22.00% |
| 2014-09-30 | 21.37% |
| 2014-06-30 | 19.19% |
| 2014-03-31 | 16.94% |
| 2013-12-31 | 17.20% |
| 2013-09-30 | 18.99% |
| 2013-06-30 | 17.55% |
| 2013-03-31 | 18.87% |
| 2012-12-31 | 19.70% |
| 2012-09-30 | 18.60% |
| 2012-06-30 | 19.96% |
| 2012-03-31 | 20.33% |
| 2011-12-31 | 20.78% |
| 2011-09-30 | 19.45% |
| 2011-06-30 | 16.76% |
| 2011-03-31 | 17.37% |
| 2010-12-31 | 17.71% |
| 2010-09-30 | 14.47% |
| 2010-06-30 | 14.70% |
| 2010-03-31 | 14.82% |
| 2009-12-31 | 15.46% |
| 2009-09-30 | 16.37% |
| 2009-06-30 | 16.83% |
| 2009-03-31 | 17.63% |
| 2008-12-31 | 18.85% |
| 2008-09-30 | 20.30% |
| 2008-06-30 | 20.12% |
| 2008-03-31 | 17.37% |
| 2007-12-31 | 17.56% |
| 2007-09-30 | 17.87% |
| 2007-06-30 | 15.79% |
| 2007-03-31 | 13.15% |
| 2006-12-31 | 12.02% |
| 2006-09-30 | 8.95% |
| 2006-06-30 | 10.64% |
| 2006-03-31 | 10.02% |
| 2005-12-31 | 9.32% |
| 2005-09-30 | 12.60% |
| 2005-06-30 | 12.06% |
| 2005-03-31 | 12.37% |
| 2004-12-31 | 8.28% |
| 2004-09-30 | -0.44% |
| 2004-06-30 | -2.98% |
| 2004-03-31 | -4.92% |
| 2003-12-31 | -2.30% |
| 2003-09-30 | -4.59% |
| 2003-06-30 | -2.63% |
